葛根素

分析標(biāo)準(zhǔn)品,HPLC≥98%

Puerarin

CAS號(hào)：3681-99-0

分子式：C21H20O9

分子量：416.38

MDL：MFCD00076007

別名：葛根黃酮；8-beta-D-葡萄吡喃糖-4',7-二羥基異黃酮

產(chǎn)品介紹

葛根素是從葛根中提取的異黃酮，是5-HT2C受體拮抗劑。

熔點(diǎn)：187-189℃

沸點(diǎn)：791.2 ℃ at 760 mmHg

外觀：白色針狀結(jié)晶

溶解性：DMSO:50mg/mL(120.08mM;Needultrasonic)

儲(chǔ)存條件：2-8℃

注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶(hù)參考交流研究之用。

參考文獻(xiàn)(134篇)

134. [IF=3.3] Zhang Wengang et al."Identification and in vitro antioxidant and hypoglycemic activities of phenolic compounds in the different solvent fractions of polyphenols from black highland barley."Journal of Food Measurement and Characterization.2025 May;:1-14

133. [IF=5.9] Ping Lin et al."Impact of filtration processes on the key chemical components of Shanxi aged vinegar."Food Bioscience.2025 Jul;69:106827

132. [IF=5.4] Xintao Ni et al."Gegen Huazhuo Tang (GHT) inhibits 7-KDCA and increases TGR5 to promote white fat browning."JOURNAL OF ETHNOPHARMACOLOGY.2025 Aug;352:120266

131. [IF=8] Peng Man et al."Ultrasonic regulation of β-lactoglobulin/puerarin complex: structural modification, digestive properties, and allergenicity suppression through controlled polyphenol interactions."FOOD RESEARCH INTERNATIONAL.2025 Jul;:117074

130. [IF=3.2] Zhang Xinyu et al."Gegen Qinlian Decoction protects kidney in diabetic rats by improving intestinal barrier and regulating intestinal microbiota."JOURNAL OF PHARMACY AND PHARMACOLOGY.2025 May;:

129. [IF=4.7] Shuai Wang et al."Cinnamaldehyde enhances the intervention effect of puerarin on stroke from the perspectives of pharmacokinetics and pharmacodynamics."EUROPEAN JOURNAL OF PHARMACOLOGY.2025 May;:177732

128. [IF=4.9] Yaping Chen et al."Active Constituent of HQS in T2DM Intervention: Efficacy and Mechanistic Insights."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2025 Jan;26(10):4578

127. [IF=7.3] Xiang Yulan et al."Puerarin relives inflammation, bone destruction and facilitates osteogenic differentiation in periodontitis by enhancing mitochondrial autophagy via activating mitochondrial Mitofusin 2."Stem Cell Research & Therapy.2025 Dec;16(1):1-21

126. [IF=6] Meiqi Liu et al."A comprehensive strategy integrating chemical profiling with deep learning for screening the antithrombin bioactive-chemical quality markers of functional food: Pueraria radix as an example."LWT-FOOD SCIENCE AND TECHNOLOGY.2024 Oct;210:11

125. [IF=4.8] Xiaoqiang Zou et al."Composite enzymatic hydrolysis for producing Harlikar apple juice with increased dietary fiber content and antioxidant capacity."Food Bioscience.2024 Dec;62:105508

124. [IF=5.6] Siyi Ma et al."Integration of feature-based molecular networking and high-definition data-dependent acquisition for the comprehensive multicomponent characterization of Honghua Xiaoyao Tablet."TALANTA.2025 Apr;285:127298

123. [IF=3.8] Xu Wang et al."A HPLC-assisted mathematical prediction method of ternary solvent systems to develop an intelligent online selection system for countercurrent chromatography solvent system."JOURNAL OF CHROMATOGRAPHY A.2024 Dec;:465585

122. [IF=6.7] Jiayang Tang et al."Downregulation of cardiac inflammation via the CaMKII δ/NF-κB pathway in heart failure by Lonicerae Japonicae Flos and Angelicae Sinensis Radix."PHYTOMEDICINE.2024 Dec;:156326

121. [IF=3.1] Jia Nini et al."UPLC-Q-TOF–MS and network pharmacology to reveal the mechanism of Guizhi Gegen decoction against type 2 diabetes mellitus."NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY.2025 Mar;:1-15

120. [IF=7.7] Xiangchen Su et al."Microenvironmental pH modulating oxygen self-boosting microalgal prodrug carboxymethyl chitosan/hyaluronic acid/puerarin hydrogel for accelerating wound healing in diabetic rats."INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES.2024

119. [IF=4.3] Yaping Chen et al."Scientific Validation of Using Active Constituent as Research Focus in Traditional Chinese Medicine: Case Study of Pueraria lobata Intervention in Type 2 Diabetes."Pharmaceuticals.2024 Dec;17(12):1675

118. [IF=4.7] Xiaoxu Fan et al."Puerarin Ameliorates the Ferroptosis in Diabetic Liver Injure Through the JAK2/STAT3 Pathway Inhibition Based on Network Pharmacology and Experimental Validation."Drug Design Development and Therapy.

117. [IF=9.4] Xiangchen Su et al."Microneedles loaded with l-arginine-modified puerarin-derived carbon nanoparticles improved treatment of diabetic wound via photothermal and nitric oxide-based gas therapy."JOURNAL OF COLLOID AND INTERFACE SCIENCE.2025 Mar;:137353

116. [IF=6.6] Guangzhe Xu et al."Anti-Inflammatory Combination of Puerarin and Ac2-26 Using Intranasal Delivery for Effective Against Ischemic Stroke in Rat Model."International Journal of Nanomedicine.

115. [IF=1.5] Qian Xiaojing et al."Qualitative, Quantitative Analysis and Pharmacokinetic Study of Potentially Active Components of Huangxueyishen Decoction Based on UPLC-MS/MS."JOURNAL OF CHROMATOGRAPHIC SCIENCE.2025 Apr;63(4):

114. [IF=4.4] Yuhang Xu et al."Therapeutic effects of medicinal and food-based traditional herbal couples on type 2 diabetes mellitus based on pharmacodynamics and pharmacokinetics."Frontiers in Pharmacology.2025 Apr;16:

113. [IF=4.2] Jingbao Chen et al."Preparation of cubic liquid crystal nanoparticles of puerarin and its protective effect on ischemic stroke."Nanomedicine-Nanotechnology Biology and Medicine.2024 Sep;:102786

112. [IF=4.8] Junjie Chen et al."A novel framework for uncovering the coordinative spectrum-effect correlation of the effective components of Yangyin Tongnao Granules on cerebral ischemia-reperfusion injury in rats."JOURNAL OF ETHNOPHARMACOLOGY.2025 Jan;337:118844

111. [IF=4.8] Yu-Jie Chen et al."Electrochemical biosensor based on functional nanomaterials and horseradish peroxidase for the determination of luteolin in peanut shell, honeysuckle and perilla."BIOELECTROCHEMISTRY.2025 Feb;161:108827

110. [IF=4.9] Zhongda Cao et al."Baicalin Inhibits FIPV Infection In Vitro by Modulating the PI3K-AKT Pathway and Apoptosis Pathway."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2024 Jan;25(18):9930

109. [IF=3.3] Jiang Mengcheng et al."Optimization of the extraction process for Shenshou Taiyi powder based on Box-Behnken experimental design, standard relation, and FAHP-CRITIC methods."BMC Complementary Medicine and Therapies.2024 Dec;24(1):1-10

108. [IF=4.8] Hongying Dong et al."Pueraria lobata antioxidant extract ameliorates non-alcoholic fatty liver by altering hepatic fat accumulation and oxidative stress."JOURNAL OF ETHNOPHARMACOLOGY.2024 Oct;333:118468

107. [IF=4.2] Ting Lu et al."18β-Glycyrrhetinic acid synergizes with enzalutamide to counteract castration-resistant prostate cancer by inhibiting OATP2B1 uptake of dehydroepiandrosterone."EUROPEAN JOURNAL OF PHARMACOLOGY.2024 Sep;:176995

106. [IF=22.7] Chang Su et al."Miniature and cost-effective self-powered triboelectric sensing system toward rapid detection of puerarin concentration."InfoMat.2024 Sep;:e12624

105. [IF=2.9] Changqi Dai et al."Puerarin alleviates oxaliplatin-induced neuropathic pain by promoting Nrf2/GPX4-mediated antioxidative response."PLoS One.2024 Aug;19(8):e0308872

104. [IF=5] Xueqiang Nie et al."The Inhibitory Impact of a Co-Assembly Gel with Natural Carrier-Free Binary Small Molecules, as Used in Traditional Chinese Medicine, on the Viability of SW1990 Cells."Gels.2024 Sep;10(9):569

103. [IF=4.3] Hujun Du et al."Exploring the Underlying Mechanisms of Qingxing Granules Treating H1N1 Influenza Based on Network Pharmacology and Experimental Validation."Pharmaceuticals.2024 Jun;17(6):731

102. [IF=6.7] Zujian Hu et al."Puerarin suppresses macrophage M1 polarization to alleviate renal inflammatory injury through antagonizing TLR4/MyD88-mediated NF-κB p65 and JNK/FoxO1 activation."PHYTOMEDICINE.2024 Jun;:155813

101. [IF=6.1] Shu Liu et al."Puerarin Delays Mammary Gland Aging by Regulating Gut Microbiota and Inhibiting the p38MAPK Signaling Pathway."JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY".2024;XXXX(XXX):XXX-XXX

100. [IF=6.1] Shiyan Yue et al."A Highly Sensitive and Rapid Colloidal Gold Immunoassay for Puerarin Detection."JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY".2024;XXXX(XXX):XXX-XXX

99. [IF=6.1] Weixin Li et al."Free and bound phenolic profiles of Radix Puerariae Thomsonii from different growing regions and their bioactivities."Food Chemistry-X".2024 Apr;:101355

98. [IF=7.9] Pin Gong et al."Metabolomic analysis of the Puerarin hypoglycemic activity via AMPK-mTOR and PPARγ-NF-κB signaling pathways."PHYTOMEDICINE".2024 Apr;:155546

97. [IF=5] Hairong Chen et al."Multi-functional D-alpha-tocopheryl polyethylene glycol succinate surface modified nanocrystals improve the stability and oral bioavailability of pueraria flavonoids."JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY".2024 May;95:105623

96. [IF=3.3] Yi-feng Ma et al."Optimization of the Zhou Tian Formula extraction technology based on AHP-CRITIC method and analysis of transfer efficiency of key components based on HPLC fingerprinting."PHYTOCHEMICAL ANALYSIS".2024 Feb;:

95. [IF=2.9] Xiaomei Zhao et al."Mechanism of Xing 9 Ling tablet candy for alcoholic liver disease based on network pharmacology."ANALYTICAL BIOCHEMISTRY".2024 Apr;:115534

94. [IF=3.3] Yuxin Zhang et al."Comprehensive quality control of Qingjin Yiqi granule based on UHPLC-Q-Orbitrap-MS and UPLC-QQQ-MS."PHYTOCHEMICAL ANALYSIS.10.1002/pca.3283

93. [IF=6] Zeru Xu et al."Targeted screening of baicalein inhibitor with controlling lipid and protein oxidation for quality preservation of grass carp fillets."LWT-FOOD SCIENCE AND TECHNOLOGY.2023 Nov;:115526

92. [IF=3.4] Ruo-yan Yang et al."Pharmacokinetics, anti-rheumatoid arthritis activity, and active ingredient contents of Eucommia ulmoides Oliv."FITOTERAPIA.10.1016/j.fitote.2023.105667

91. [IF=5.6] Yan Duan et al."UPLC-Q–TOF–MS, network analysis, and molecular docking to investigate the effect and active ingredients of tea-seed oil against bacterial pathogens."Frontiers in Pharmacology.10.3389/fphar.2023.1225515

90. [IF=5.4] Chang Zhou et al."Neuroprotective effects of Jie-du-huo-xue decoction on microglia pyroptosis after cerebral ischemia and Reperfusion——From the perspective of glial-vascular unit."JOURNAL OF ETHNOPHARMACOLOGY.2023 Aug;:116990

89. [IF=5.195] Jingwen Xu et al."Puerarin-Tanshinone IIA Suppresses atherosclerosis inflammatory plaque via targeting succinate/HIF-1α/IL-1β axis."JOURNAL OF ETHNOPHARMACOLOGY.2023 May;:116675

88. [IF=4.927] Jie Zhang et al."Enhancement of Polyphenols and Antioxidant Activity in Germinated Black Highland Barley by Ultrasonication."MOLECULES.2023 Jan;28(9):3679

87. [IF=6.656] Siqi Liu et al."Screening quality makers (Q-makers) of Xiaoer Chaige Tuire Oral Liquid by in vitro sequential metabolism and in vivo biopharmaceutical analysis."PHYTOMEDICINE.2023 Apr;:154844

86. [IF=4.927] Wengang Zhang et al."Polyphenol Profile and In Vitro Antioxidant and Enzyme Inhibitory Activities of Different Solvent Extracts of Highland Barley Bran."MOLECULES.2023 Jan;28(4):1665

85. [IF=5.561] Yuan Gao et al."Determination of Isoflavones in Radix puerariae from Different Origins by Ultra-High Performance Liquid Chromatography Based on Optimal Pretreatment Method."Foods.2023 Jan;12(4):794

84. [IF=5.195] Xiaojing Wang et al."Gegen Qinlian decoction activates AhR/IL-22 to repair intestinal barrier by modulating gut microbiota-related tryptophan metabolism in ulcerative colitis mice."JOURNAL OF ETHNOPHARMACOLOGY.2022 Nov;:115919

83. [IF=6.208] Pan Wang et al."Discovery of Flavonoids as Novel Inhibitors of ATP Citrate Lyase: Structure–Activity Relationship and Inhibition Profiles."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2022 Jan;23(18):10747

82. [IF=11.614] Pengfei He et al."Structural mechanism of a dual-functional enzyme DgpA/B/C as both a C-glycoside cleaving enzyme and an O- to C-glycoside isomerase."Acta Pharmaceutica Sinica B. 2022 May;:

81. [IF=2.552] Wang Sha et al."A newly isolated human intestinal strain deglycosylating flavonoid C-glycosides."ARCHIVES OF MICROBIOLOGY. 2022 Jun;204(6):1-8

80. [IF=5.34] Lei Jin et al."Simultaneous optimization of the extraction process of Yangyin Yiqi Huoxue prescription with natural deep eutectic solvents for optimal extraction yield and antioxidant activity: A comparative study of two models."PHYTOMEDICINE. 2022 Jul;102

79. [IF=4.412] Haifan Liu et al."Pharmacokinetics, Prostate Distribution and Metabolic Characteristics of Four Representative Flavones after Oral Administration of the Aerial Part of Glycyrrhiza uralensis in Rats."MOLECULES. 2022 Jan;27(10):3245

78. [IF=5.682] Hengyue Zhu et al."The isoflavone puerarin exerts anti-tumor activity in pancreatic ductal adenocarcinoma by suppressing mTOR-mediated glucose metabolism."Aging-Us. 2021 Dec 15; 13(23): 25089–25105

77. [IF=5.396] Jie Li et al."Cryptochlorogenic acid and its metabolites ameliorate myocardial hypertrophy through a HIF1α-related pathway."Food Funct. 2022 Jan;:

76. [IF=0.986] Na Li et al."Comparative Tissue Distribution of 6 Major Polyphenolic Compounds in Normal and Myocardial Ischemia Model Rats After Oral Administration of the Polygonum orientale L. Extract:."Nat Prod Commun. 2020;15(6):

75. [IF=1.902] Yuan Lu et al."Comparative analysis of excretion of six major compounds of Polygonum orientale L. extract in urine, feces and bile under physiological and myocardial ischemia conditions in rats using UPLC–MS/MS."Biomed Chromatogr. 2021 Oct;35(10):e5174

74. [IF=2.082] Qin Guo et al."Synergistic inhibition effects of tea polyphenols as adjuvant of oxytetracycline on Vibrio parahaemolyticus and enhancement of Vibriosis resistance of Exopalaemon carinicauda."Aquac Res. 2021 Aug;52(8):3900-3910

73. [IF=2.574] Zeng  Mao-Seng et al."Puerarin reduces impairment of intestinal and adipose immune responses to influenza virus infection in mice."Arch Virol. 2021 Sep;166(9):2387-2397

72. [IF=2.826] Kai  Sheng et al."Simple voltammetric sensor detection for puerarin."Int J Environ An Ch. 2021;101(12):1635-1648

71. [IF=2.984] Chenkai Wang et al."Comparative transcriptome analysis of roots, stems, and leaves of Pueraria lobata (Willd.) Ohwi: identification of genes involved in isoflavonoid biosynthesis."Peerj. 2021 Feb;9:e10885

70. [IF=3] Qu  Lala et al."Phenotypic assessment and ligand screening of ETA/ETB receptors with label-free dynamic mass redistribution assay."N-S Arch Pharmacol. 2020 Jun;393(6):937-950

69. [IF=3.361] Mengmeng Yuan et al."The interaction of dietary flavonoids with xanthine oxidase in vitro: molecular property-binding affinity relationship aspects."Rsc Adv. 2019 Apr;9(19):10781-10788

68. [IF=3.422] Wei  Bin et al."Discovery of novel glycoside hydrolases from C-glycoside-degrading bacteria using sequence similarity network analysis."J Microbiol. 2021 Oct;59(10):931-940

67. [IF=3.512] Yan Cheng et al."Comparison of the Extraction Efficiency of Isoflavone Compounds from Puerariae lobatae by Ionic Liquids with 11 Anions and 8 Imidazolium-Based Cations."Acs Omega. 2020;5(15):8962–8971

66. [IF=3.869] Huang Donghua et al."Puerarin Relieved Compression-Induced Apoptosis and Mitochondrial Dysfunction in Human Nucleus Pulposus Mesenchymal Stem Cells via the PI3K/Akt Pathway."Stem Cells Int. 2020;2020:7126914

65. [IF=3.943] Lumeng Niu et al."Puerarin inhibits Mycoplasma gallisepticum (MG-HS)-induced inflammation and apoptosis via suppressing the TLR6/MyD88/NF-κB signal pathway in chicken."Int Immunopharmacol. 2020 Nov;88:106993

64. [IF=4.171] Song Liu et al."In silico-determined compound from root of Pueraria lobate alleviates synaptic plasticity injury induced by Alzheimer's disease via p38MAPK-CREB signaling pathway."Food Funct. 2021 Feb;12(3):1039-1050

63. [IF=4.759] Lu-lu Xu et al."Rapid quantitation and identification of the chemical constituents in Danhong Injection by liquid chromatography coupled with orbitrap mass spectrometry."J Chromatogr A. 2019 Nov;1606:460378

62. [IF=4.759] Wenjie Wu et al."An analytical strategy for accurate, rapid and sensitive quantitative analysis of isoflavones in traditional Chinese medicines using ultra-high performance supercritical fluid chromatography: Take Radix Puerariae as an example."J Chromato

61. [IF=4.872] Muhammad Waqas et al."Puerarin enhance vascular proliferation and halt apoptosis in thiram-induced avian tibial dyschondroplasia by regulating HIF-1α, TIMP-3 and BCL-2 expressions."Ecotox Environ Safe. 2020 Mar;190:110126

60. [IF=5.455] Yu  Yunru et al."Identification of anti-inflammatory compounds from Zhongjing formulae by knowledge mining and high-content screening in a zebrafish model of inflammatory bowel diseases."Chin Med-Uk. 2021 Dec;16(1):1-14

59. [IF=5.878] Hui-Xian Wang et al."Antiviral activity of puerarin as potent inhibitor of influenza virus neuraminidase."Phytother Res. 2021 Jan;35(1):324-336

58. [IF=7.132] Li Yang et al."Supercritical extraction and antioxidant activity of major ingredients in Puerariae lobatae root, Pinus massoniana needle, Citrus reticulata peel and their mixture."J Co2 Util. 2021 Jun;48:101518

57. [IF=2.19] Y.J. Chen et al."Phytochemical Profiles of Edible Kudzu (Pueraria thomsonii Benth) Grown in China as Affected by Thermal Processing."J Food Process Pres. 2017 Feb;41(1):e12754

56. [IF=2.896] Bo Li et al."Preparative separation of isoflavones in plant extract of Pueraria lobata by high performance counter-current chromatography."Anal Methods-Uk. 2015 Feb;7(4):1321-1327

55. [IF=3.361] Hongguang Zhang et al."Extraction of isoflavones from Puerariae lobata using subcritical water."Rsc Adv. 2018 Jun;8(40):22652-22658

54. [IF=3.645] Wenjie Wu et al."Simple, rapid, and environmentally friendly method for the separation of isoflavones using ultra-high performance supercritical fluid chromatography."J Sep Sci. 2017 Jul;40(13):2827-2837

53. [IF=3.738] Selma Houchi et al."Investigation of common chemical components and inhibitory effect on GES-type β-lactamase (GES22) in methanolic extracts of Algerian seaweeds."Microb Pathogenesis. 2019 Jan;126:56

52. [IF=5.396] Song Liu et al."The in silico and in vivo evaluation of puerarin against Alzheimer's disease."Food Funct. 2019 Feb;10(2):799-813

51. [IF=6.057] Shasha Jing et al."A novel electrochemical sensor based on WO3 nanorods-decorated poly(sodium 4-styrenesulfonate) functionalized graphene nanocomposite modified electrode for detecting of puerarin."Talanta. 2017 Nov;174:477

50. [IF=6.321] Jifen Zhang et al."Development of an Oral Compound Pickering Emulsion Composed of Nanocrystals of Poorly Soluble Ingredient and Volatile Oils from Traditional Chinese Medicine."Pharmaceutics. 2018 Dec;10(4):170

49.  Yu, Yunru, et al. "Identification of anti-inflammatory compounds from Zhongjing formulae by knowledge mining and high-content screening in a zebrafish model of inflammatory bowel diseases." Chinese medicine 16.1 (2021): 1-14.

48.  Zhang, Jifen, et al. "Development of an oral compound pickering emulsion composed of nanocrystals of poorly soluble ingredient and volatile oils from traditional chinese medicine." Pharmaceutics 10.4 (2018): 170.https:##doi.org/10.3390/pharmaceutics1004017

47.  Huang, W, Wen, Z, Wang, M, Xu, B, Zhou, B, Li, X. Anticomplement and antitussive activities of major compound extracted from Chimonanthus nitens Oliv. leaf. Biomedical Chromatography. 2020; 34:e4736. https:##doi.org/10.1002/bmc.4736

46.  Li, Na, et al. "Comparative Tissue Distribution of 6 Major Polyphenolic Compounds in Normal and Myocardial Ischemia Model Rats After Oral Administration of the Polygonum orientale L. Extract." Natural Product Communications 15.6 (2020): 1934578X20929447.ht

45.  Renshu, Huang, et al. "Extraction technology of isoflavone from Dabie Mountain's Pueraria lobata and determination of its reducing power." Pakistan journal of pharmaceutical sciences 27 (2014).

44.  Shasha Jing, Huijun Zheng, Li Zhao, Lingbo Qu, Lanlan Yu,

A novel electrochemical sensor based on WO3 nanorods-decorated poly(sodium 4-styrenesulfonate) functionalized graphene nanocomposite modified electrode for detecting of puerarin,

Talanta,

Volume 174

43.  李承浩,王萌,任曉亮.磺化杯6芳烴對(duì)4類(lèi)中藥單體成分增溶作用及其機(jī)制研究[J].中國(guó)現(xiàn)代中藥,2020,22(12):2032-2038.

42.  鞠娜,張文風(fēng),翁麗麗.正交實(shí)驗(yàn)法優(yōu)選玉液湯提取工藝[J].特產(chǎn)研究,2021,43(01):7-11.

41.  陳函,廉婷,杜遠(yuǎn)東,陳程,馬寶.鼻用葛根素脂質(zhì)體溫敏凝膠劑的制備與質(zhì)量評(píng)價(jià)[J].化工科技,2020,28(05):41-46.

40.  劉春花,王明金,楊淑婷,黎娜,陸苑,潘潔,李勇軍,王永林,孫佳.基于外翻腸囊模型研究葒草提取物在正常和心肌缺血模型大鼠中的腸吸收特征[J].中國(guó)中藥雜志,2021,46(01):196-205.

39.  王晶,趙重博,唐家琪,卜雕雕,鄒俊波,張小飛,程江雪,王昌利.高效液相色譜法同時(shí)測(cè)定復(fù)方龍脈寧中7種成分的含量[J].中南藥學(xué),2020,18(11):1903-1905.

38.  范琳,王苗,馬馨桐,沈穎昕,韓榮欣,張紅印,嚴(yán)銘銘,邵帥.葛根抗氧化活性有效部位的篩選研究[J].食品研究與開(kāi)發(fā),2021,42(06):119-123.

37.  陳豐,陳志清,鐘桂玲,王賀,朱繼金.葛根素預(yù)處理對(duì)心肌梗死模型大鼠HMGB1的表達(dá)及心肌細(xì)胞凋亡的影響[J].廣西醫(yī)科大學(xué)學(xué)報(bào),2020,37(08):1404-1409.

36.  楊夢(mèng)玲, 尤朋濤, 何麗珊,等. 基于UPLC-MS/MS分析胃潰瘍模型大鼠口服加味小柴胡顆粒后血漿中8種有效成分的藥代動(dòng)力學(xué)[J]. 中國(guó)中藥雜志, 2018, 43(18).

35.  任麗, 賈田芊, 李興歡,等. 黃花油點(diǎn)草藥材的質(zhì)量標(biāo)準(zhǔn)研究[J]. 中國(guó)藥房, 2019, 030(008):1083-1090.

34.  侯景龍, 毛跟年, 胡媛,等. 葛根,枳椇子解酒組合物體外抗氧化活性的研究[J]. 動(dòng)物醫(yī)學(xué)進(jìn)展, 2020, 041(002):63-69.

33.  牛曉靜, 曹英杰, 段曉穎. 多指標(biāo)正交試驗(yàn)優(yōu)選通絡(luò)調(diào)脂膠囊提取工藝[J]. 中藥新藥與臨床藥理, 2015, 026(006):851-854.

32.  潘潔, 楊淑婷, 孫佳, et al. 葒草中6種活性成分在正常和心肌缺血模型大鼠體內(nèi)的腸吸收特征差異研究[J]. 中國(guó)藥房, 2020(13).

31.  吳文杰 鄧陽(yáng) 譚桂林 羅娟 陳秧 黃鶯 張峰.一測(cè)多評(píng)法測(cè)定葛根藥材中5種異黃酮類(lèi)成分[J].中草藥 2017 48(04):777-781.

30.  黃仁術(shù), 胡曉夢(mèng), 何惠利. 大別山野葛根異黃酮超聲輔助提取工藝的響應(yīng)面優(yōu)化與還原力測(cè)定[J]. 中國(guó)藥學(xué)雜志, 2015, 50(001):51-57.

29.  李玲, 全沁果, 沈艷欣, et al. 野葛藤地上部分葛根素的提取及穩(wěn)定性研究[J]. 食品工業(yè)科技, 2016, 37(9):235-239.

28.  李玲, 郭慧, 何福林,等. 野葛花葛根素的提取及穩(wěn)定性研究[J]. 中國(guó)食品添加劑, 2017(3).

27.  李玲, 譚力, 全沁果,等. 野葛塊根異黃酮的提取及抗氧化研究[J]. 浙江農(nóng)業(yè)學(xué)報(bào), 2016, v.28;No.160(03):496-501.

26.  嚴(yán)航, 楊晶, 唐婷,等. 葛根黃酮脂質(zhì)體的制備及體外透皮實(shí)驗(yàn)研究[J]. 中成藥, 2014, 36(003):623-625.

25.  桂卉,唐婷,嚴(yán)航,雷志鈞.葛根黃酮類(lèi)物質(zhì)美白作用的研究[J].日用化學(xué)工業(yè),2013,43(04):290-293+312.

24.  胡亞麗,楊杰,龐茜茜.葛根素通過(guò)PTEN/PI3K/Akt通路調(diào)控人肝癌HepG2細(xì)胞增殖和凋亡的研究[J].現(xiàn)代消化及介入診療,2020,25(07):883-888.

23.  王帥, 李清清, 王帆,等. 葛根素藥物納米晶自穩(wěn)定pickering乳的大鼠腸吸收特性研究[J]. 中國(guó)中藥雜志, 2018, v.43(10):212-217.

22.  王晶, 李洪敏, 艾芳,等. 葛根素的提取及對(duì)小鼠解酒護(hù)肝功能的鑒定[J]. 局解手術(shù)學(xué)雜志, 2015(04):358-361.

21.  陳媛, 吳海金, 黃曉松,等. 葛根素對(duì)腦缺血再灌注大鼠海馬組織P-STAT3、P53表達(dá)的影響[J]. 湖南中醫(yī)藥大學(xué)學(xué)報(bào), 2018, 038(001):36-39.

20.  張曉丹, 杜偉, 張晨,等. 葛根素對(duì)缺氧性肺動(dòng)脈高壓及伴隨的肺纖維化的作用[J]. 中國(guó)中藥雜志, 2018, 43(12).

19.  陳媛, 黃曉松, 吳海金,等. 葛根素對(duì)大鼠腦缺血再灌注損傷后JAK2/STAT3信號(hào)通路的影響[J]. 湖南中醫(yī)雜志, 2017, 04(v.33;No.218):149-152+170.

18.  劉銀莉, 王營(yíng). 葛根素對(duì)人胰腺癌PANC-1細(xì)胞增殖凋亡的影響[J]. 實(shí)用藥物與臨床, 2017(11):20-24.

17.  宋逍, 段璽, 徐萌,等. 葛根中有效成分葛根素膜分離工藝研究[J]. 時(shí)珍國(guó)醫(yī)國(guó)藥, 2019(10).

16.  ]滕飛[1], 李博[1], 謝靜[1],等. 葛根中抑制磷酸二酯酶4活性成分的篩選研究[J]. 分子科學(xué)學(xué)報(bào)(中,英文), 2018(1).

15.  陳松旺, 吳婷, 李煌,等. 暢脈樂(lè)膠囊的質(zhì)量標(biāo)準(zhǔn)研究[J]. 福建醫(yī)藥雜志, 2020, 042(001):127-132.

14.  溫海成, 楊穎欣, 葉信,等. 正交試驗(yàn)優(yōu)選壯藥三裂葉葛藤中葛根素的提取工藝研究[J]. 中國(guó)民族醫(yī)藥雜志, 2016(9).

13.  晏雨露, 徐驛, 趙繼會(huì),等. 微針輔助條件下葛根素微乳的經(jīng)皮吸收研究[J]. 中草藥, 2017, 048(001):95-101.

12.  李博,趙安琦,張慧榮,李麗.應(yīng)用超濾液相色譜和電噴霧質(zhì)譜技術(shù)篩選MMP-2活性成分[J].分子科學(xué)學(xué)報(bào),2015,31(02):94-100.

11.  馬曉云,劉洋,楊瑞瑞,羅志強(qiáng),魯利娜,趙海譽(yù),趙慧輝.封閉腸環(huán)法用于葛根多成分腸壁吸收代謝研究[J].中國(guó)中藥雜志,2017,42(08):1532-1538.

10.  楊玉琴, 昶國(guó)平, 張志超,等. 復(fù)方丹參保肝顆粒入血成分研究[J]. 現(xiàn)代中藥研究與實(shí)踐, 2016, 030(003):37-40.

9.  陸苑,黎娜,劉春花,潘潔,李勇軍,王永林,孫佳.基于在體腸袢模型研究葒草活性成分在正常及心肌缺血模型大鼠的腸吸收特性[J].中國(guó)藥理學(xué)通報(bào),2020,36(08):1146-1151.

8.  陳程,羅國(guó)平,馮鎖民,張存勞,閆夢(mèng)茹,郭艷茹.基于PB設(shè)計(jì)和BBD響應(yīng)面法優(yōu)化葛根-黃連藥對(duì)提取工藝[J].中國(guó)藥師,2018,21(02):228-231.

7.  羅靜, 陳詩(shī)晴, 李玉鋒,等. 基于Box-Behnken設(shè)計(jì)優(yōu)化復(fù)方葛根黃酮泡騰片的制備工藝研究[J]. 食品工業(yè), 2018, v.39;No.262(07):175-180.

6.  王京龍, 鄭丹丹, 王磊,等. 均勻設(shè)計(jì)法優(yōu)化葛根半仿生提取工藝[J]. 中成藥, 2017(5).

5.  卜雕雕  張丹  王昌利. 響應(yīng)面法優(yōu)化藥對(duì)葛根-川芎提取工藝[J]. 遼寧中醫(yī)藥大學(xué)學(xué)報(bào)  2019  021(004):54-57.

4.  黃仁術(shù)  孫崢崢  何惠利. 響應(yīng)面法優(yōu)化大別山野葛根多糖提取工藝研究[J]. 藥物生物技術(shù)  2015  022(001):59-63.

3.  昶國(guó)平  魏雅蕾  林宏英 等. 丹葛保肝復(fù)方提取工藝的研究[J]. 中醫(yī)藥學(xué)報(bào)  2015(03):76-78.

2.  張麗娟  李燕  周劍麗 等. 一種降糖代餐粉的配方研究及質(zhì)量評(píng)價(jià)[J]. 食品研究與開(kāi)發(fā)  2019  40(09):105-110.

1.  崔靈  張麗姝  陳萌萌 等. HPLC法同時(shí)測(cè)定知葛膠囊中葛根素、馬錢(qián)苷、芒果苷以及蘆丁的含量[J]. 沈陽(yáng)藥科大學(xué)學(xué)報(bào)  2018(7).

從2011年開(kāi)始我們致力于在生命科學(xué)領(lǐng)域、生物醫(yī)學(xué)實(shí)驗(yàn)技術(shù)及論文潤(rùn)色服務(wù)，協(xié)助客戶(hù)各類(lèi)實(shí)驗(yàn)服務(wù)及論文潤(rùn)色十余年，是您值得信賴(lài)的科研合作伙伴!

如果您受時(shí)間、試驗(yàn)條件等限制而無(wú)法完成您的課題研究，歡迎您與我們聯(lián)系。

實(shí)驗(yàn)技術(shù)服務(wù)：